Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

7.00CAD
21 Sep 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.00
Open
$7.42
Day's High
$7.48
Day's Low
$7.00
Volume
68,596
Avg. Vol
27,088
52-wk High
$9.50
52-wk Low
$5.68

Chart for

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 2.13
Market Cap(Mil.): $689.24
Shares Outstanding(Mil.): 83.54
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.70 -- --
ROI: -60.83 1.79 14.61
ROE: -70.80 3.28 16.33

Earnings vs. Estimates